A Nested Case-Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis
Maha F Yousif1, Katie D Dolak1, Soumya Adhikari1
1Division of Pediatric Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390-9063, USA.
The Journal of Clinical Endocrinology and Metabolism
|December 10, 2024
Summary
Children with diabetic ketoacidosis (DKA) or hyperglycemic-hyperosmolar syndrome (HHS) experiencing adverse outcomes often present with hypernatremia. This condition, present on admission and persisting during treatment, is linked to poorer outcomes, not management differences.
Area of Science:
- Pediatric Endocrinology
- Critical Care Medicine
- Metabolic Disorders
Background:
- Adverse Outcomes in pediatric diabetic ketoacidosis (DKA) and hyperglycemic-hyperosmolar syndrome (HHS) are predictable by a composite risk score.
- Most high-risk patients do not experience adverse outcomes, necessitating identification of other influencing factors.
Purpose of the Study:
- To identify clinical characteristics and management differences associated with adverse outcomes in pediatric DKA-HHS.
- To investigate factors beyond the composite risk score that impact patient outcomes.
Main Methods:
- A nested case-control study was conducted on 4565 admissions for DKA-HHS (2010-2023).
- 84 cases with adverse outcomes were matched with 84 controls based on a composite risk score.
- Analysis focused on initial clinical data and treatment course differences.
Main Results:
- Cases with adverse outcomes showed higher initial serum sodium and BUN, and more new-onset diabetes.
- Hyperglycemia, acidosis, and hypernatremia resolved slower in the case group.
- No significant differences were found in fluid administration or initial insulin doses, but cases required IV insulin longer.
Conclusions:
- Persistent hypernatremia at admission and during the first 24 hours of treatment is a key indicator of adverse outcomes in pediatric DKA-HHS.
- These adverse outcomes are not explained by differences in clinical management strategies.
Related Concept Videos
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K


